Explore
Validate
Learn
ELISA
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10369-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10369-1-AP, RRID:AB_2099548
- Product name
- ERBB3 antibody
- Antibody type
- Polyclonal
- Description
- ERBB3 antibody (Cat. #10369-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Quantitative systems pharmacology modeling of HER2-positive metastatic breast cancer for translational efficacy evaluation and combination assessment across therapeutic modalities.
The novel antibody fusion protein rhNRG1-HER3i promotes heart regeneration by enhancing NRG1-ERBB4 signaling pathway.
Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis.
CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis.
NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes.
Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells.
NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells.
ErbB1 and ErbB2 overexpression in patients with sinonasal inverted papilloma and inverted papilloma with squamous cell carcinoma in China.
Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.
Zhou YT, Chu JH, Zhao SH, Li GL, Fu ZY, Zhang SJ, Gao XH, Ma W, Shen K, Gao Y, Li W, Yin YM, Zhao C
Acta pharmacologica Sinica 2024 Jun;45(6):1287-1304
Acta pharmacologica Sinica 2024 Jun;45(6):1287-1304
The novel antibody fusion protein rhNRG1-HER3i promotes heart regeneration by enhancing NRG1-ERBB4 signaling pathway.
Wang X, Wu H, Tang L, Fu W, He Y, Zeng C, Wang WE
Journal of molecular and cellular cardiology 2024 Feb;187:26-37
Journal of molecular and cellular cardiology 2024 Feb;187:26-37
Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis.
You H, Yuan D, Li Q, Zhang N, Kong D, Yu T, Liu X, Liu X, Zhou R, Kong F, Zheng K, Tang R
International journal of biological macromolecules 2023 Jan 31;226:996-1009
International journal of biological macromolecules 2023 Jan 31;226:996-1009
CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis.
Zhang Y, Tan D, Xie Y, Wu L, Wu S, Tang Y, Luo Y, Xiao X, Li X
Journal of oncology 2022;2022:1028851
Journal of oncology 2022;2022:1028851
NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes.
Leng R, Meng Y, Sun X, Zhao Y
Frontiers in oncology 2022;12:1057198
Frontiers in oncology 2022;12:1057198
Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells.
Adediran S, Wang L, Khan MA, Guang W, Fan X, Dan H, Qi J, Jay SM, Carrier F, Hussain A
Cancers 2022 Sep 23;14(19)
Cancers 2022 Sep 23;14(19)
NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells.
Liu WJ, Huang YX, Wang W, Zhang Y, Liu BJ, Qiu JG, Jiang BH, Liu LZ
Cells 2021 Jun 30;10(7)
Cells 2021 Jun 30;10(7)
ErbB1 and ErbB2 overexpression in patients with sinonasal inverted papilloma and inverted papilloma with squamous cell carcinoma in China.
Li H, Hu L, Zhang H, Wang D
Acta oto-laryngologica 2019 Dec;139(12):1104-1111
Acta oto-laryngologica 2019 Dec;139(12):1104-1111
Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.
Lu M, Wang T, He M, Cheng W, Yan T, Huang Z, Zhang L, Zhang H, Zhu W, Zhu Y, Liu P
Oncotarget 2017 Apr 4;8(14):23008-23019
Oncotarget 2017 Apr 4;8(14):23008-23019
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human prostate cancer using 10369-1-AP(ERBB3 antibody) at dilution of 1:10 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ERBB3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ERBB3. This antibody recognizes human, mouse, rat antigen. The ERBB3 antibody has been validated for the following applications: ELISA, IHC analysis.
